Meet Our Management Team
Lawrence Robbins, MD
Dr. Lawrence Robbins, M.D. is a distinguished neurologist with over four decades of experience in clinical practice, research, and education. Dr. Robbins is a Master Psychopharmacologist and Master Clinician, as awarded by the Neuroscience Education Institute. He has participated in numerous multi-center drug trials as a principal investigator having served on advisory boards for Glaxo, Pfizer, AstraZeneca, Medpoint, Allergan, Abbvie, Teva, Merck, Lilly, and Novartis. A recognized leader in the field, Dr. Robbins has authored or contributed to more than 400 articles and abstracts and has written six books. He has been nominated for numerous practice and teaching awards and has received humanitarian awards for a clinic he established in Honduras.
Chief Financial Officer
Evelyn Logan
Evelyn Logan is a Colorado based CPA that specializes in helping senior management of growth companies enhance profitability and prepare for successful business exits. Ms. Logan has over 30-years of experience in corporate operations, mergers and acquisitions across diverse industries, including healthcare, professional services and SaaS companies. She specializes in driving bottom-line growth through strategic planning and financial optimization. Ms. Logan served on the Colorado Governor’s Task Force on Fraud and is a partner at Social Venture Partners. Her past leadership roles include serving as President of the Chatsworth Chamber of Commerce Board, Treasurer of the Bloom Again Foundation, and Treasurer of the YMCA in Northridge, California.
Operations
Amy Shaft
Amy Shaft is a seasoned clinical research professional with 19-years of experience specializing in multi-site operations, project management, and team leadership. She has a proven track record of guiding organizations through transitions, enhancing performance, reducing costs, and cultivating a culture of excellence. As a former Director of Site Operations for a Fortune 100 healthcare company, Amy successfully managed organizational integration following an acquisition. She held full accountability for all research studies, ensuring adherence to best practices, and regulatory compliance. Amy exceeded enrollment targets by 30% for two high-priority global vaccine studies demonstrating her expertise in driving impactful results.
